In mouse models and in humans with active pulmonary tuberculosis, both IL-17- and IL-22-producing CD4+ T cells as well as IL-17+γδ T cells were shown to contribute to the antimycobacterial immune response [21, 22]. This evidence concerns the gene IL17A and pulmonary tuberculosis.